CD5 is induced based on the intensity of the TCR-MHC-1 interaction and poorly immunogenic tumor microenvironments that can lead to T cells with reduced CD5: a situation promoting increased TCR-MHC-I interaction and enhanced T cell activation. Here, CD5 is linked to neoplasm.